New blood pressure guidelines: supporters get coverage, critics don’t. Why?
Do published SPRINT study results live up to premature NIH news release hype?
NIH SPRINT study sparks questions about overtreatment of mild hypertension
The Economics & Politics of Drugs for Mild Hypertension
Waste & Harm in the Treatment of Mild Hypertension: overtreatment, industry influence